» Authors » Kimon C Zachary

Kimon C Zachary

Explore the profile of Kimon C Zachary including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 847
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dugdale C, Zachary K, Craig R, Doms A, Germaine L, Green C, et al.
Infect Control Hosp Epidemiol . 2025 Jan; :1-9. PMID: 39743817
Background: The study objective was to develop and validate a clinical decision support system (CDSS) to guide clinicians through the diagnostic evaluation of hospitalized individuals with suspected pulmonary tuberculosis (TB)...
2.
Dugdale C, Zachary K, McEvoy D, Branda J, Courtney A, Craig R, et al.
Open Forum Infect Dis . 2024 Jun; 11(6):ofae253. PMID: 38872849
Background: For persons with suspected pulmonary tuberculosis, the guidelines of the Centers for Disease Control and Prevention recommend collecting 3 respiratory specimens 8 to 24 hours apart for acid-fast bacilli...
3.
Zachary K, Philpotts L, Shenoy E
Curr Opin Infect Dis . 2023 Jul; 36(4):257-262. PMID: 37431555
Purpose Of Review: The risk of nosocomial transmission of mpox during the 2022 global outbreak is not well described. We evaluated reports of exposures to healthcare personnel (HCP) and patients...
4.
Shenoy E, Wright S, Barbeau D, Foster L, King A, Gordon P, et al.
Ann Intern Med . 2022 Nov; 175(12):1639-1647. PMID: 36343347
Background: In May 2022, the first case of monkeypox virus (MPXV) infection in the United States in the current global outbreak was identified. As part of the public health and...
5.
Turbett S, Tomkins-Tinch C, Anahtar M, Dugdale C, Hyle E, Shenoy E, et al.
Clin Infect Dis . 2022 Oct; 76(5):850-860. PMID: 36268576
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection is poorly understood, partly because few studies have systematically applied genomic analysis to distinguish reinfection from persistent RNA detection related to...
6.
Zachary K, Shenoy E
Infect Control Hosp Epidemiol . 2022 Jun; 43(7):920-924. PMID: 35676244
Transmission risk of monkeypox in healthcare settings outside endemic regions has not been well defined. A rapid review of the literature, including cases outside monkeypox-endemic regions from 2000 to 2022...
7.
Lagerborg K, Normandin E, Bauer M, Adams G, Figueroa K, Loreth C, et al.
Nat Microbiol . 2021 Dec; 7(1):108-119. PMID: 34907347
The global spread and continued evolution of SARS-CoV-2 has driven an unprecedented surge in viral genomic surveillance. Amplicon-based sequencing methods provide a sensitive, low-cost and rapid approach but suffer a...
8.
Dugdale C, Anahtar M, Chiosi J, Lazarus J, McCluskey S, Ciaranello A, et al.
Open Forum Infect Dis . 2021 Jun; 8(1):ofaa559. PMID: 34164560
Background: Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19)...
9.
Mohareb A, Rosenberg J, Bhattacharyya R, Kotton C, Chu J, Jilg N, et al.
J Immigr Minor Health . 2021 Jun; 23(6):1343-1347. PMID: 34159495
Immunomodulating therapies for COVID-19 may carry risks of reactivating latent infections in foreign-born people. We conducted a rapid review of infection-related complications of immunomodulatory therapies for COVID-19. We convened a...
10.
Egbuonu K, Hyle E, Hurtado R, Alba G, Zachary K, Branda J, et al.
Open Forum Infect Dis . 2021 Jun; 8(6):ofab257. PMID: 34113690
Among hospitalized persons under investigation for coronavirus disease 2019 (COVID-19), more repeated severe acute respiratory syndrome coronavirus 2 nucleic acid amplification tests (NAATs) after a negative NAAT were positive from...